Adaptive trial designs in rheumatology: Report from the OMERACT Special Interest Group

Pickles, Tim ORCID: https://orcid.org/0000-0001-7743-0234, Alten, Rieke, Boers, Maarten, Bykerk, Vivian, Christensen, Jared, Christensen, Robin, van Hoogstraten, Hubert, Simon, Lee S., Tam, Lai-Shan and Choy, Ernest H. ORCID: https://orcid.org/0000-0003-4459-8609 2019. Adaptive trial designs in rheumatology: Report from the OMERACT Special Interest Group. Journal of Rheumatology 46 (10) , pp. 1406-1408. 10.3899/jrheum.181054

Preview

PDF - Accepted Post-Print Version Download (334kB) | Preview

Abstract

Objective: Adaptive trial design was developed initially for oncology to improve trial efficiency. If optimized for rheumatology, it may improve trial efficiency by reducing sample size and time. Methods: A systematic review assessed design of phase II clinical trials in rheumatoid arthritis. Results: Fifty-six trials were reviewed. Most trials had 4 groups (1 control and 3 intervention), with an average group size of 34 patients. American College of Rheumatology 20 measured at 16 weeks was the most commonly used primary endpoint. Conclusion: The next step is to undertake a systematic review of adaptive designs used in early-phase trials in nonrheumatic conditions.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine Centre for Trials Research (CNTRR)
Publisher:	Journal of Rheumatology
ISSN:	0315-162X
Date of First Compliant Deposit:	25 February 2019
Date of Acceptance:	18 December 2018
Last Modified:	02 Dec 2024 18:15
URI:	https://orca.cardiff.ac.uk/id/eprint/119832

Citation Data

Cited 5 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item